In the News
February 5, 2020
Bloomberg Law, Reuters | Laterals, Moves, Promotions
Related News & Insights
-
General Publications March 3, 2025“How to Conduct Internal Investigations When a Whistleblower Is Involved: A Strategic Approach,” Corporate Counsel, March 3, 2025.This article details a strategic approach to conducting internal investigations when a whistleblower is involved.
-
In the News January 30, 2025New York Law Journal | Attorneys ‘On the Move’: O’Melveny Hires Former NBA Vice President; MoFo Adds Venture Capital PartnerChris Borchert, Andrew Ligotti, and Reade Seligmann are noted for their election as Alston & Bird partners.
-
In the News January 10, 2025New York Law Journal | Attorneys on the Move: Morrison Cohen Expands White Collar Practice; O’Melveny Brings Back Corporate Finance PartnerChris Borchert, Andrew Ligotti, and Reade Seligmann are noted for their election as partners in New York.
-
Speaking Engagement November 19, 2024Preparing for Your Next or First Voir DireMia Falzarano presented on the topic "Preparing for Your Next (or First) Voir Dire, with Help from AI" at the Higginbotham Inn of Court November meeting.
-
Press Release November 19, 2024Alston & Bird Secures Multimillion-Dollar Award for Cigna in Suit Against LabsAlston & Bird has won a $7.3 million award for Cigna Health & Life Insurance Co. in its lawsuit against three South Florida clinical laboratories for wrongfully billing Cigna for medically unnecessary drug tests. After an eight-day trial, a federal jury in New Haven, Connecticut returned a verdict in Cigna’s favor for $7.3 million.
-
Press Release November 15, 2024Alston & Bird Secures Litigation Win for SandozOn November 4, Alston & Bird secured over $70 million in damages for client Sandoz in litigation against biopharmaceutical firm United Therapeutics Corp. (UTC). In 2019, Sandoz filed a suit alleging UTC blocked the sale of a generic version of hypertension medication by colluding with the manufacturer of infusion pumps for injecting UTC’s brand-name hypertension drug Remodulin to muscle out Sandoz’s generic alternative. Following a three-day bench trial, U.S. District Judge Brian R. Martinotti found Sandoz lost profits of $137.2 million and entered a judgment in favor of Sandoz, awarding damages of $61.6 million, plus prejudgment interest of $8.9 million, on its breach of contract claim against UTC. The win was featured in The American Lawyer’s Litigator of the Week, Law360’s Legal Lions column, and The New Jersey Law Journal.
-
Press Release November 13, 2024Alston & Bird Earns “Powerhouse” Ranking in BTI Consulting Group’s 2025 Litigation OutlookAlston & Bird has been recognized in eight practice categories within BTI Consulting Group’s 2025 Litigation Outlook. This annual report is based exclusively on in-depth surveys and interviews with leading legal decision-makers.
-
Press Release November 7, 2024Alston & Bird Earns 126 Tier-1 Rankings in 2025 Best Law FirmsAlston & Bird has been honored as one of the nation’s top law firms in the 2025 edition of Best Law Firms®, ranked by Best Lawyers.
-
Press Release October 7, 2024Alston & Bird Obtains Dismissal with Prejudice for Former CEO of Philips RespironicsAlston & Bird obtained a dismissal with prejudice for John Frank, the former CEO of health technology company Philips Respironics, in a securities class action in the Eastern District of New York. All claims against Frank were dismissed with prejudice after years-long litigation that culminated in argument on the motion in April.
-
General Publications September 25, 2024“Employer Tips For PUMP Act Compliance As Law Turns 2,” Law360, September 25, 2024.This article discusses actionable steps employers can take to comply with lactation-space requirements under the PUMP Act and related state laws.
Media Contact
- Business Litigation
- Antitrust
- Class Action & Multidistrict Litigation
- Corporate Plaintiff's Litigation
- Government Contracts
- International Arbitration & Dispute Resolution
- Appellate
- Federal & International Tax
- Real Estate
- REITs
- Private Equity
- Joint Ventures & Investments
- Private Investment Funds
- Corporate Debt Finance
- Finance
- Corporate & Business Transactions
- Exempt Organizations
- Capital Markets & Securities
- Hospitality